close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Ray Therapeutics

News headline image
Ray Therapeutics Appoints Michael Murtagh as Chief Regulatory Officer
From Ray Therapeutics
Via Business Wire
News headline image
Ray Therapeutics Appoints Scott Braunstein, M.D., as Chairman of the Board of Directors
From Ray Therapeutics
Via Business Wire
News headline image
Ray Therapeutics Awarded $8M CIRM Grant to Advance RTx-015 Gene Therapy for Retinitis Pigmentosa
From Ray Therapeutics
Via Business Wire
News headline image
Ray Therapeutics Appoints Christopher Whitmore as Chief Financial Officer
From Ray Therapeutics
Via Business Wire
News headline image
Ray Therapeutics Receives $4M in Funding from The California Institute for Regenerative Medicine (CIRM)
From Ray Therapeutics
Via Business Wire
News headline image
Ray Therapeutics Announces Promotion of Jenny Holt to Chief Development Officer
From Ray Therapeutics
Via Business Wire
News headline image
Ray Therapeutics Closes Oversubscribed $100M Series A Financing to Advance Optogenetic Gene Therapies for Blinding Diseases
From Ray Therapeutics
Via Business Wire
News headline image
Ray Therapeutics to Present at Upcoming Scientific Conferences
From Ray Therapeutics
Via Business Wire
News headline image
Ray Therapeutics Appoints Dr. Peter Francis as Chief Scientific & Medical Officer and Jenny Holt as SVP, Program Portfolio Management
From Ray Therapeutics
Via Business Wire
News headline image
Ray Therapeutics Receives $4M in Funding From the California Institute for Regenerative Medicine (CIRM)
From Ray Therapeutics
Via Business Wire
News headline image
Ray Therapeutics Closes $6M Seed Financing to Advance Novel Optogenetics Platform to Treat Blinding Diseases
From Ray Therapeutics
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today